ArticleNeuro-oncology advances

Beyond proof-of-concept: Validating robust automated diffuse lower-grade glioma segmentation for clinical applications in longitudinal follow-up.

Jeremy Deverdun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.